International Biotechnology Trust’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-316,133
| Closed | -$4.59M | – | 66 |
|
|
2022
Q3 | $4.59M | Buy |
316,133
+312,373
| +8,308% | +$4.53M | 1.47% | 22 |
|
|
2022
Q2 | $383K | Sell |
3,760
-379,473
| -99% | -$38.7M | 4% | 6 |
|
|
2022
Q1 | $10.8M | Hold |
383,233
| – | – | 2.44% | 15 |
|
|
2021
Q4 | $5.07M | Hold |
383,233
| – | – | 1.13% | 29 |
|
|
2021
Q3 | $6.69M | Buy |
383,233
+100,000
| +35% | +$1.74M | 1.61% | 21 |
|
|
2021
Q2 | $6.79M | Buy |
283,233
+68,700
| +32% | +$1.65M | 1.79% | 19 |
|
|
2021
Q1 | $5.49M | Buy |
214,533
+37,100
| +21% | +$949K | 1.45% | 21 |
|
|
2020
Q4 | $3.37M | Hold |
177,433
| – | – | 0.92% | 23 |
|
|
2020
Q3 | $2.23M | Hold |
177,433
| – | – | 0.72% | 27 |
|
|
2020
Q2 | $2.25M | Sell |
177,433
-50,000
| -22% | -$633K | 0.75% | 26 |
|
|
2020
Q1 | $1.73M | Sell |
227,433
-50,000
| -18% | -$381K | 0.79% | 24 |
|
|
2019
Q4 | $4.92M | Buy |
277,433
+100,000
| +56% | +$1.77M | 1.77% | 21 |
|
|
2019
Q3 | $2.06M | Sell |
177,433
-10,166
| -5% | -$118K | 0.95% | 25 |
|
|
2019
Q2 | $4.17M | Sell |
187,599
-25,462
| -12% | -$565K | 1.54% | 21 |
|
|
2019
Q1 | $6.06M | Sell |
213,061
-106,383
| -33% | -$3.03M | 2.24% | 15 |
|
|
2018
Q4 | $4.95M | Sell |
319,444
-2,992
| -0.9% | -$46.4K | 3.07% | 12 |
|
|
2018
Q3 | $5.47M | Hold |
322,436
| – | – | 2.6% | 15 |
|
|
2018
Q2 | $2.61M | Hold |
322,436
| – | – | 1% | 35 |
|
|
2018
Q1 | $3.01M | Hold |
322,436
| – | – | 1.17% | 23 |
|
|
2017
Q4 | $3.14M | Hold |
322,436
| – | – | 1.11% | 27 |
|
|
2017
Q3 | $2.15M | Hold |
322,436
| – | – | 0.84% | 33 |
|
|
2017
Q2 | $2.28M | Hold |
322,436
| – | – | 0.86% | 36 |
|
|
2017
Q1 | $2.52M | Hold |
322,436
| – | – | 0.96% | 28 |
|
|
2016
Q4 | $2.19M | Buy |
+322,436
| New | +$2.19M | 0.98% | 22 |
|